Student Name
Capella University
NURS-FPX 4060 Practicing in the Community to Improve Population Health
Prof. Name
Date
Health Promotion Plan
Community health initiatives focus on addressing specific health concerns within defined populations by considering social, cultural, and environmental factors. These programs aim to empower individuals to manage their physical, mental, social, and cultural well-being. Successful community health initiatives begin with a thorough assessment of the needs and conditions of the population they serve (Barker et al., 2021). Without long-term preventive strategies, recurring health problems may persist. Therefore, a comprehensive approach that evaluates multiple determinants of health is critical to reducing disease prevalence and improving overall community well-being. Such programs often include educational campaigns and health literacy initiatives to increase awareness of ongoing health risks (Naqvi & Gale, 2020).
A prominent public health concern is Human Papillomavirus (HPV), a widely prevalent sexually transmitted infection that can lead to serious long-term health consequences. According to the Centers for Disease Control and Prevention (CDC), about 19,000 women and 12,000 men in the United States contract HPV annually (CDC, 2021). HPV is linked to multiple types of cancer, including cervical, anal, oral, throat, and penile cancers. Women are disproportionately affected, with approximately 4,000 deaths each year attributed to cervical cancer. High-risk groups include men who have sex with men, individuals with multiple sexual partners, sexually abused children, and immunocompromised individuals (WHO, 2023). Often asymptomatic, HPV may first be detected through visible genital warts, which can signal infection or increased cancer risk. This health promotion plan focuses on strategies to prevent HPV and increase public awareness.
Analysis of Health Concerns
HPV remains highly prevalent in the United States, with an estimated 42.5 million people currently infected (Elflein, 2023). Because the virus can remain dormant for several years, many individuals are unaware of their infection until complications arise. Genital warts are observed in roughly 1 out of every 100 people.
Cervical cancer affects around 12,000 women annually in the U.S. (CDC, 2021). Infection rates are strongly associated with sexual activity, and women exhibit higher incidence than men. Globally, approximately 625,000 women and 69,000 men develop HPV-related cancers each year (WHO, 2023).
HPV encompasses over 150 strains, though only a subset is considered high-risk for cancer or genital warts. Socioeconomic disparities exist: women from low- and middle-income households are more vulnerable to HPV infection compared to those from higher-income backgrounds (Galeshi et al., 2022). The psychological impact of HPV-related cancer diagnosis can be significant, producing anxiety, fear, guilt, and social stigma (Amboree & Darkoh, 2020).
Preventive measures primarily include HPV vaccination and regular screening. Vaccination is recommended for preteens aged 11–12 and up to 26 years for those not previously immunized (CDC, 2021). Adults older than 26 should continue with routine screenings for early cancer detection. Given HPV’s asymptomatic nature and its physical, mental, and social health implications, proactive prevention strategies are essential (Galeshi et al., 2022).
Assumptions and Uncertainties
Several misconceptions about HPV persist, including the belief that HPV-related cancers are untreatable. In reality, cervical and other HPV-associated cancers can be effectively prevented or managed through vaccination and regular screenings. Vaccines are most effective for individuals under 26, while adults aged 26–45 may see limited protective benefits (Kim et al., 2021).
Challenges in HPV prevention include vaccination compliance among youth and adults, the cost and accessibility of educational programs in low-income communities, and psychosocial impacts such as fear, shame, and stigma. These emotional responses vary among individuals, affecting adherence to preventive strategies (Kim et al., 2021).
Need for Health Promotion
Cervical cancer ranks as the fourth leading cause of cancer-related deaths in women globally, with over 600,000 new cases and 342,000 deaths in 2020 (WHO, 2022). Women from low- and middle-income communities often face barriers to preventive care and treatment. Co-infections, such as HIV, amplify the risk of developing cervical cancer by sixfold (Clarke et al., 2021).
HPV infection primarily occurs between ages 15 and 25, influenced by behavioral factors such as multiple sexual partners and unsafe sexual practices, and biological factors including compromised immunity (Clarke et al., 2021). Disparities are notable: women, especially Black women, are more frequently diagnosed than men and White women, while individuals from low- and middle-income households face higher risks (Amboree & Darkoh, 2020). Targeted health promotion initiatives are therefore critical to reducing HPV prevalence among young women (Naqvi & Gale, 2020).
Factors Involved in Health Disparities
HPV-related disparities are shaped by race, gender, income, age, geographic location, and healthcare access. The following table summarizes these disparities:
| Factor | Description of Disparity |
|---|---|
| Race | Black women have higher rates of HPV-related cervical cancer than White women. |
| Sex | Men are less likely to seek preventive measures despite being carriers. |
| Income | Low-income households face financial and access barriers to vaccination and treatment. |
| Age | HPV infection peaks at 15–25, though cancer can develop up to age 60. |
| Geography | Southern U.S. regions report higher HPV prevalence than northern regions. |
| Healthcare Access | Minority populations often experience limited or biased access to HPV services. |
These disparities highlight the importance of culturally sensitive health promotion programs that address access, awareness, and adherence to preventive strategies (Correl, 2023).
Agreed Upon Health Goals
Case Example: Maria, a 22-year-old Latina diagnosed with early-stage cervical cancer linked to HPV, faces emotional, physical, social, and financial challenges. SMART goals (Specific, Measurable, Achievable, Relevant, Time-bound) were developed to guide interventions (White et al., 2020).
| Goal | Intervention | Expected Outcome |
|---|---|---|
| Reduce financial burden by 60% in 6 months | Enroll in insurance programs and utilize free community clinics | Improved economic stability and treatment adherence |
| Educate on HPV and dispel myths | Participate in 3–6 workshops (online and in-person) over 3 months | Enhanced knowledge, reduced anxiety, and increased preventive behaviors |
| Improve social support | Join online support groups | Reduced isolation, improved coping with social stigma |
| Enhance emotional well-being | Weekly counseling sessions for 3 months | Increased emotional resilience and mental health support |
These goals empower Maria by addressing financial, educational, social, and emotional needs. Participation in workshops and counseling led to improved confidence, better coping strategies, and adherence to preventive health measures.
Conclusion
This health promotion plan underscores the importance of preventing and managing HPV-related cervical cancer. Because HPV often remains asymptomatic, early intervention through vaccination, regular screening, and education is crucial. Implementing SMART goals supports holistic care by addressing physical, emotional, and social dimensions of health. Combining education, financial assistance, and psychosocial support allows individuals to manage HPV risk effectively and enhances overall community health outcomes.
References
Amboree, T. L., & Darkoh, C. (2020). Barriers to human papillomavirus vaccine uptake among racial/ethnic minorities: A systematic review. Journal of Racial and Ethnic Health Disparities. https://doi.org/10.1007/s40615-020-00877-6
Barker, S. L., Maguire, N., Gearing, R. E., Cheung, M., Price, D., Narendorf, S. C., & Buck, D. S. (2021). A community-engaged healthcare model for currently under-served individuals involved in the healthcare system. SSM – Population Health, 15, 100905. https://doi.org/10.1016/j.ssmph.2021.100905
NURS FPX 4060 Assessment 1 Health Promotion Plan
CDC. (2021, January 19). STD Facts – Human PapillomaVirus (HPV). CDC. https://www.cdc.gov/std/hpv/stdfact-hpv.htm
Clarke, M. A., Risley, C., Stewart, M. W., Geisinger, K. R., Hiser, L. M., Morgan, J. C., … & Wentzensen, N. (2021). Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi. Cancer Medicine, 10(23), 8641–8650. https://doi.org/10.1002/cam4.4340
Correl, R. (2023, December 5). How health disparities can impact HPV-related cancers. Verywell Health. https://www.verywellhealth.com/health-disparities-in-hpv-related-cancers-4173225#:~:text=Health%20disparities%20are%20differences%20in
NURS FPX 4060 Assessment 1 Health Promotion Plan
Elflein, J. (2023, August 31). Topic: Human papillomavirus (HPV) in the U.S. Statista. https://www.statista.com/topics/5094/human-papillomavirus-hpv-in-the-us/#topicOverview
Galeshi, M., Shirafkan, H., Yazdani, S., & Motaghi, Z. (2022). Reproductive health needs of Human PapillomaVirus (HPV) positive women: A systematic review. PLOS One, 17(9), e0266819. https://doi.org/10.1371/journal.pone.0266819
Naqvi, R., & Gale, O. (2020). Preventative health screening community events, a mechanism to target minority ethnic populations in improving primary care utilisation to improve health outcomes. British Journal of General Practice, 70(suppl 1), bjgp20X711005. https://doi.org/10.3399/bjgp20x711005
Kim, J. J., Simms, K. T., Killen, J., Smith, M. A., Burger, E. A., Sy, S., … & Canfell, K. (2021). Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLOS Medicine, 18(3), e1003534. https://doi.org/10.1371/journal.pmed.1003534
WHO. (2022). Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
WHO. (2023, August 23). Human papillomavirus and cancer. https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer